Wong, Y. W, Thomas, L., Sun, J. L, McMurray, J., Krum, H., Hernandez, A. F, Rutten, G. E, Leiter, L. A, Standl, E., Haffner, S. M, Mazzone, T., Martinez, F., Tognoni, G., Giles, T. D & Califf, RM. (2013). Predictors of incident heart failure hospitalizations among patients with impaired glucose tolerance : insight from the nateglinide and valsartan in impaired glucose tolerance outcomes research study. Circulation: Heart Failure,6(2), 203-210. United States: Lippincott Williams & Wilkins. Retrieved from https://doi.org/10.1161/CIRCHEARTFAILURE.112.000086
Impaired glucose tolerance and metabolic syndrome are associated with increased risk of heart failure (HF). However, predictors associated with the increased risk of incident HF have not been well characterized. We aimed to identify independent predictors of incident HF hospitalization among patients with impaired glucose tolerance.
Mary MacKillop Institute for Health Research
Access may be restricted.